“…In an age when randomized control trials, which remain our gold standard, take more than 5 years to yield usable results, and the grant support for such work has decreased substantially, it is unlikely that research can be conducted to reflect every iteration of comorbidity within and between families of young children with DBDs will be feasible. There are, however, recommendations for more idiographic, functional models of assessment that may lend themselves quite well to further understanding for whom the potential cascading effects of BPT may be most beneficial (O’Brian, Haynes, & Kaholokula, 2016; Silverman & Kearney, 1991). In particular, the extent to which parent and/or child behavior, as well as parent-child interactions, are functioning to maintain and/or exacerbate internalizing symptomatology in children and/or depression in caregivers, as well as DBDs, may predict which families will be most likely to benefit from the secondary effects of BPT.…”